Clinical trials
Lipedema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 11 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Recruiting | 15 |
| Not yet recruiting | 12 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 2 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatih Sultan Mehmet Training and Research Hospital | 5 |
| Marmara University | 5 |
| Cairo University | 4 |
| Gazi University | 4 |
| Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 4 |
| Dokuz Eylul University | 3 |
| Istanbul Physical Medicine Rehabilitation Training and Research Hospital | 3 |
| University of Arizona | 3 |
| Caliway Biopharmaceuticals Co., Ltd. | 2 |
| Helse Nord-Trøndelag HF | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipedema | 82 |
| Pain | 13 |
| Obesity | 7 |
| Lymphedema | 6 |
| Adiposis Dolorosa | 5 |
| Overweight | 3 |
| Chronic Pain | 2 |
| Connective Tissue Diseases | 2 |
| Erythema Multiforme | 2 |
| Inflammation | 2 |
Trials
Showing 26 to 50 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.